{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:49:06Z","timestamp":1783457346266,"version":"3.55.0"},"reference-count":19,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,12,2]]},"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Efficacy of aliskiren combination therapy with other antihypertensive has been evaluated in the treatment of patients with hypertension in recent systematic reviews. However, most previous reviews only focused on one single health outcome or one setting, none of them made a full summary that assessed the impact of aliskiren combination treatment comprehensively. As such, this umbrella review based on systematic reviews and meta-analyses is aimed to synthesise the evidences on efficacy, safety and tolerability of aliskiren-based therapy for hypertension and related comorbid patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A comprehensive search of PubMed, EMBASE, Cochrane Library, CNKI published from inception to August 2020 will be conducted. The selected articles are systematic reviews which evaluated efficacy, safety and tolerability of aliskiren combination therapy. Two reviewers will screen eligible articles, extract data and evaluate quality independently. Any disputes will be resolved by discussion or the arbitration of a third person. The quality of reporting evidence will be assessed using the Assessment of Multiple Systematic Reviews V.2 tool tool. We will take a mixed-methods approach to synthesising the review literatures, reporting summary of findings tables and iteratively mapping the results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval is not required for the study, as we would only collect data from available published materials. This umbrella review will be also submitted to a peer-reviewed journal for publication after completion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42020192131.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-043807","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T10:53:30Z","timestamp":1615287210000},"page":"e043807","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of aliskiren combination therapy: a protocol for an umbrella review"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-2217","authenticated-orcid":false,"given":"Jiantong","family":"Shen","sequence":"first","affiliation":[{"name":"School of Medicine, Huzhou University; Huzhou Central Hospital, Huzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Feng","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Huzhou University, Huzhou University, Huzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yike","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Nursing, Huzhou University, Huzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2854-0845","authenticated-orcid":false,"given":"Qiyuan","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Nursing, Huzhou University, Huzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billong Laura","family":"Flavorta","sequence":"additional","affiliation":[{"name":"School of Nursing, Huzhou University, Huzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Nursing, Huzhou University, Huzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"key":"2025121403122497000_11.3.e043807.1","doi-asserted-by":"publisher","DOI":"10.2165\/11204360-000000000-00000"},{"key":"2025121403122497000_11.3.e043807.2","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-020-01442-z","article-title":"Clinical efficacy, safety and tolerability of aliskiren monotherapy (am): an umbrella review of systematic reviews","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"2025121403122497000_11.3.e043807.3","first-page":"CD007066","article-title":"Blood pressure lowering efficacy of renin inhibitors for primary hypertension","volume":"4","author":"Musini","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121403122497000_11.3.e043807.4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070111","article-title":"Aliskiren and amlodipine in the management of essential hypertension: meta-analysis of randomized controlled trials","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"2025121403122497000_11.3.e043807.5","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2017-000591"},{"key":"2025121403122497000_11.3.e043807.6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/10641963.2017.1407333","article-title":"Aliskiren and valsartan in combination is a promising therapy for hypertensive renal injury in rats","volume":"40","author":"Abdel Kawy","year":"2018","journal-title":"Clin Exp Hypertens"},{"key":"2025121403122497000_11.3.e043807.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61124-6"},{"key":"2025121403122497000_11.3.e043807.8","doi-asserted-by":"publisher","DOI":"10.1185\/03007990902785845"},{"key":"2025121403122497000_11.3.e043807.9","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpt210"},{"key":"2025121403122497000_11.3.e043807.10","first-page":"1963","article-title":"Effect of aliskiren on cardiovascular outcomes in patients with prehypertension: a meta-analysis of randomized controlled trials","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"2025121403122497000_11.3.e043807.11","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000055"},{"key":"2025121403122497000_11.3.e043807.12","unstructured":"Aromataris E , Fernandez RS , Godfrey C . Methodology for JBI umbrella reviews. Adelaide, Australia: The Joanna Briggs Institute, 2014."},{"key":"2025121403122497000_11.3.e043807.13","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"2025121403122497000_11.3.e043807.14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-15-219"},{"key":"2025121403122497000_11.3.e043807.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3453"},{"key":"2025121403122497000_11.3.e043807.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5024"},{"key":"2025121403122497000_11.3.e043807.17","doi-asserted-by":"crossref","unstructured":"Higgins JPT , Thomas J , Chandler J . Cochrane handbook for systematic reviews of interventions version 6.0. London: Cochrane, 2019. www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"key":"2025121403122497000_11.3.e043807.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.11.007"},{"key":"2025121403122497000_11.3.e043807.19","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2017-097621"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-043807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T11:12:34Z","timestamp":1765710754000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-043807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,9]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/bmjopen-2020-043807"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-043807","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}